Summary Report Tests Outside Reference Range: Cardiac Risk Markers Complete Hemogram

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010
NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

REF. BY : DR.... (2105053207),NATIONAL PATHOLOGY CENTER,MAIN
TEST ASKED : ESR,ROUTINE URINE ANALYSIS,AAROGYAM CAMP PROFILE ROAD BERI TIRAHA,IN FRONT OF DR
2 PRAJAPATI,KURARA, HAMIRPUR,UTTAR
Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
LIPOPROTEIN (A) [LP(A)] 55.77 mg/dL < 30
COMPLETE HEMOGRAM
MEAN CORP.HEMO.CONC(MCHC) 29.4 g/dL 31.5-34.5
MEAN PLATELET VOLUME(MPV) 13.5 fL 6.5-12
PLATELET DISTRIBUTION WIDTH(PDW) 19.6 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 52.4 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.3 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.6 fL 39.0-46.0
LIPID
HDL / LDL RATIO 0.4 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 69 mg/dL 40-60
LDL CHOLESTEROL - DIRECT 174 mg/dL < 100
NON-HDL CHOLESTEROL 163.53 mg/dL < 160
TOTAL CHOLESTEROL 233 mg/dL < 200
OTHER COUNTS
ERYTHROCYTE SEDIMENTATION RATE (ESR) 60 mm / hr 0 - 20
RENAL
CREATININE - SERUM 0.54 mg/dL 0.55-1.02
URINOGRAM
NITRITE PRESENT - Absent
VITAMINS
25-OH VITAMIN D (TOTAL) 15.3 ng/mL 30-100
Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

REF. BY (2105053207),NATIONAL PATHOLOGY
: DR....
CENTER,MAIN ROAD BERI TIRAHA,IN FRONT OF
TEST ASKED : ESR,HbA1c,HEMOGRAM DR PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505
TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 4.8 %
Bio. Ref. Interval. :
Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 91 mg/dL
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 03 Apr 2024 07:45
Sample Received on (SRT) : 04 Apr 2024 04:04

Report Released on (RRT) : 04 Apr 2024 05:42
Sample Type : EDTA
Labcode : 0304043424/UP130 Dr.Shaffaly Gagneja MD (Path)
Barcode : CB005167
Page : 1 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

REF. BY : DR.... (2105053207),NATIONAL PATHOLOGY
CENTER,MAIN ROAD BERI TIRAHA,IN FRONT OF DR
TEST ASKED : ESR,HbA1c,HEMOGRAM
PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505

ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 60 mm / hr
Bio. Ref. Interval. :-
Male : 0-15
Female : 0-20

Method:- MODIFIED WESTERGREN

Sample Type : EDTA
Dr.Shaffaly Gagneja MD (Path)
Labcode : 0304043424/UP130
Barcode : CB005167 Page : 2 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

TEST ASKED : ESR,HbA1c,HEMOGRAM
DR PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) HF & FC 8.13 X 10³ / µL 4.0 - 10.0
NEUTROPHILS Flow Cytometry 65.2 % 40-80
LYMPHOCYTE Flow Cytometry 28 % 20-40
MONOCYTES Flow Cytometry 3.8 % 2-10
EOSINOPHILS Flow Cytometry 2.1 % 1-6
BASOPHILS Flow Cytometry 0.6 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) Flow Cytometry 0.3 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT Calculated 5.3 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT Calculated 2.28 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT Calculated 0.31 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT Calculated 0.05 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT Calculated 0.17 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) Calculated 0.02 X 10³ / µL 0.0-0.3
TOTAL RBC HF & EI 4.41 X 10^6/µL 3.8-4.8
NUCLEATED RED BLOOD CELLS Calculated 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % Flow Cytometry 0.01 % 0.0-5.0
HEMOGLOBIN SLS-Hemoglobin Method 12.5 g/dL 12.0-15.0
HEMATOCRIT(PCV) CPH Detection 42.5 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) Calculated 96.4 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) Calculated 28.3 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) Calculated 29.4 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 54.6 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) Calculated 15.3 % 11.6-14.0
PLATELET DISTRIBUTION WIDTH(PDW) Calculated 19.6 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) Calculated 13.5 fL 6.5-12
PLATELET COUNT HF & EI 190 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) Calculated 52.4 % 19.7-42.4
PLATELETCRIT(PCT) Calculated 0.26 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Type : EDTA
Barcode : CB005167 Page : 3 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

(2105053207),NATIONAL PATHOLOGY
REF. BY : DR....
TEST ASKED : ROUTINE URINE ANALYSIS PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.015 - 1.003-1.030
PH pH indicator 5.5 - 5-8
Chemical Examination
URINARY PROTEIN Protein error ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling PRESENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5

Sample Type : URINE
Labcode : 0304043532/UP130
Barcode : U4059252 Page : 4 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

: DR....
TEST ASKED : AAROGYAM CAMP PROFILE 2 DR PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505
25-OH VITAMIN D (TOTAL) C.L.I.A 15.3 ng/mL

DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic
syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.
Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
Method : Fully Automated Chemi Luminescent Immuno Assay
VITAMIN B-12 C.L.I.A 545 pg/mL
Normal : 211 - 911 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml
Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;
1987:569–73.
Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Barcode : CA663311
Page : 5 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

: DR....
TEST ASKED : AAROGYAM CAMP PROFILE 2 DR PRAJAPATI,KURARA, HAMIRPUR,UTTAR
PRADESH,210505
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 137 mg/dL

Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 119 mg/dL
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.9 Ratio
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : Derived from serum Apo A1 and Apo B values

Sample Type : SERUM
Barcode : CA663311
Page : 6 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

TEST ASKED : AAROGYAM CAMP PROFILE 2
PRADESH,210505

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 2.86 mg/L
< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.
Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Labcode : 0304123717/UP130
Barcode : CA663311 Page : 7 of 14
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

PRADESH,210505

LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.77 mg/dL
Adults : < 30.0 mg/dl
Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.
Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %
Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 0304123717/UP130
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

REF. BY (2105053207),NATIONAL PATHOLOGY CENTER,MAIN
: DR....
ROAD BERI TIRAHA,IN FRONT OF DR PRAJAPATI,KURARA,
TEST ASKED : AAROGYAM CAMP PROFILE 2 HAMIRPUR,UTTAR PRADESH,210505
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 233 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 69 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 174 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 98 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.4 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.42 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.4 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 163.53 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 19.68 mg/dL 5 - 40
Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

: DR....

ALKALINE PHOSPHATASE PHOTOMETRY 74.64 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.49 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.41 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 15.1 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 24.66 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 24 U/L < 34
SGOT / SGPT RATIO CALCULATED 1.03 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.48 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.2 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.28 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.28 Ratio 0.9 - 2
Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Type : SERUM

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

: DR....

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 11.65 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.54 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 21.57 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 24.93 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 46.17 Ratio < 52
CALCIUM PHOTOMETRY 9.52 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 3.84 mg/dL 3.2 - 6.1
Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Type : SERUM

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

(2105053207),NATIONAL PATHOLOGY CENTER,MAIN
REF. BY : DR....

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 94 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 6.82 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 2.9 µIU/mL 0.54-5.30
Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,

PRADESH,210505

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 112 mL/min/1.73 m2
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Method:- CKD-EPI Creatinine Equation
~~ End of report ~~

Sample Type : SERUM
Labcode : 0304123717/UP130
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
*As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)
Page : 14 of 14

Summary Report Tests Outside Reference Range: Cardiac Risk Markers Complete Hemogram

Uploaded by

Copyright:

Available Formats

Summary Report Tests Outside Reference Range: Cardiac Risk Markers Complete Hemogram

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Summary Report Tests Outside Reference Range: Cardiac Risk Markers Complete Hemogram

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 03 Apr 2024 07:45

Sample Received on (SRT) : 04 Apr 2024 04:04

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Please correlate with clinical conditions.

Sample Collected on (SCT) : 03 Apr 2024 07:45

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Please Correlate with clinical conditions.

Sample Collected on (SCT) : 03 Apr 2024 07:45

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Sample Collected on (SCT) : 03 Apr 2024 07:45

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.L.I.A 15.3 ng/mL

Normal : 211 - 911 pg/ml

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Sample Collected on (SCT) : 03 Apr 2024 07:45

Sample Received on (SRT) : 04 Apr 2024 04:04

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 137 mg/dL

Sample Collected on (SCT) : 03 Apr 2024 07:45

Sample Received on (SRT) : 04 Apr 2024 04:04

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

< 1.00 - Low Risk

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 03 Apr 2024 07:45

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Adults : < 30.0 mg/dl

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 03 Apr 2024 07:45

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

Sample Collected on (SCT) : 03 Apr 2024 07:45

Barcode : CA663311 Page : 9 of 14

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

Sample Collected on (SCT) : 03 Apr 2024 07:45

Barcode : CA663311 Page : 10 of 14

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

Sample Collected on (SCT) : 03 Apr 2024 07:45

Barcode : CA663311 Page : 11 of 14

NAME : MRS SUMAN GUPTA (48Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay